{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:12:34Z","timestamp":1789549954198,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3E1491"],"award-info":[{"award-number":["CMRPG3E1491"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW106-TDU-B-212-113005"],"award-info":[{"award-number":["MOHW106-TDU-B-212-113005"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many uncommon <jats:italic>Candida<\/jats:italic> spp. (species other than <jats:italic>C. albicans<\/jats:italic>, <jats:italic>C. parapsilosis<\/jats:italic>, <jats:italic>C. glabrata<\/jats:italic>, <jats:italic>C. tropicalis<\/jats:italic>, and <jats:italic>C. krusei<\/jats:italic>) have been shown to emerge in tertiary care facilities. We aimed to investigate these uncommon candidemia in children. Forty-six cases of candidemia caused by uncommon <jats:italic>Candida<\/jats:italic> spp. were identified during 2003\u20132015 from a medical center in Taiwan. The most common specie was <jats:italic>C. guilliermondii<\/jats:italic> (31.2%), followed by <jats:italic>C. lusitaniae<\/jats:italic> (18.8%) and <jats:italic>C. metapsilosis<\/jats:italic> (18.8%). These cases were analyzed and compared with 148 episodes of <jats:italic>C. albicans<\/jats:italic> candidemia. The incidence density of uncommon <jats:italic>Candida<\/jats:italic> spp. candidemia and the proportion to all candidemia episodes increased substantively during the study period. Prior exposure to azoles was uncommon in the 30 days prior to infection, but fluconazole resistant strains were significantly more common (n\u2009=\u200919, 41.3%). The increased incidence density of uncommon <jats:italic>Candida<\/jats:italic> spp. candidemia was associated with increasing use of antifungal agents. No differences in demographics, underlying comorbidities, risk factors, clinical features, dissemination, and 30-day mortality were found between uncommon <jats:italic>Candida<\/jats:italic> spp. and <jats:italic>C. albicans<\/jats:italic> candidemia. Patients with uncommon <jats:italic>Candida<\/jats:italic> spp. candidemia were more likely to require modifications in antifungal treatment and receive echinocandin drugs (43.5% vs 21.6%, p\u2009=\u20090.007). Candidemia caused by uncommon <jats:italic>Candida<\/jats:italic> spp. had poorer response to antifungal treatment, led to longer duration of candidemia (median 4.0 versus 2.5 days, p\u2009=\u20090.008), and had a higher treatment failure rate (56.5% vs 38.5%, p\u2009=\u20090.040).<\/jats:p>","DOI":"10.1038\/s41598-018-33662-x","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T09:48:11Z","timestamp":1539078491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes"],"prefix":"10.1038","volume":"8","author":[{"given":"Ming-Horng","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Fu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chou","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Huei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Jih","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"33662_CR1","doi-asserted-by":"publisher","first-page":"493.e1","DOI":"10.1016\/j.cmi.2014.12.024","volume":"21","author":"A Russo","year":"2015","unstructured":"Russo, A. et al. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection. Clin Microbiol Infect 21, 493.e1\u2013493.e4 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR2","doi-asserted-by":"publisher","first-page":"491.e1","DOI":"10.1016\/j.cmi.2014.12.027","volume":"21","author":"M Puig-Asensio","year":"2015","unstructured":"Puig-Asensio, M. et al. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect 21, 491.e1\u2013491.e10 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/1469-0691.12578","volume":"20","author":"C Oeser","year":"2014","unstructured":"Oeser, C. et al. Neonatal invasive fungal infection in England 2004\u20132010. Clin Microbiol Infect 20, 936\u2013941 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","volume":"21","author":"L Hesstvedt","year":"2015","unstructured":"Hesstvedt, L. et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect 21, 938\u2013945 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","volume":"21","author":"BH Tan","year":"2015","unstructured":"Tan, B. H. et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21, 946\u2013953 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR6","doi-asserted-by":"publisher","first-page":"87.e1","DOI":"10.1016\/j.cmi.2014.08.011","volume":"21","author":"L Klingspor","year":"2015","unstructured":"Klingspor, L. et al. Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008). Clin Microbiol Infect 21, 87.e1\u201387.e10 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/JCM.01790-07","volume":"46","author":"SR Lockhart","year":"2008","unstructured":"Lockhart, S. R., Messer, S. A., Pfaller, M. A. & Diekema, D. J. Lodderomyces elongisporus Masquerading as Candida parapsilosis as a cause of bloodstream infections. J Clin Microbiol 46, 374\u2013376 (2008).","journal-title":"J Clin Microbiol"},{"key":"33662_CR8","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1128\/JCM.43.8.4107-4111.2005","volume":"43","author":"J Alcoba-Fl\u00f3rez","year":"2005","unstructured":"Alcoba-Fl\u00f3rez, J. et al. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol 43, 4107\u20134111 (2005).","journal-title":"J Clin Microbiol"},{"key":"33662_CR9","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1128\/JCM.00222-07","volume":"45","author":"ZU Khan","year":"2007","unstructured":"Khan, Z. U. et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol 45, 2025\u20132027 (2007).","journal-title":"J Clin Microbiol"},{"key":"33662_CR10","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1086\/597108","volume":"48","author":"MN Kim","year":"2009","unstructured":"Kim, M. N. et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 48, e57\u2013e61 (2009).","journal-title":"Clin Infect Dis"},{"key":"33662_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1086\/318473","volume":"32","author":"A Minari","year":"2001","unstructured":"Minari, A., Hachem, R. & Raad, I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32, 186\u2013190 (2001).","journal-title":"Clin Infect Dis"},{"key":"33662_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jac\/dku321","volume":"70","author":"LS Ramos","year":"2015","unstructured":"Ramos, L. S. et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother 70, 111\u2013115 (2015).","journal-title":"J Antimicrob Chemother"},{"key":"33662_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmi.2015.09.029","volume":"22","author":"G Cuervo","year":"2015","unstructured":"Cuervo, G. et al. Breakthrough candidemia in the era of broad-spectrum antifungal therapies. Clin Microbiol Infect 22, 181\u2013188 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR14","doi-asserted-by":"publisher","first-page":"O245","DOI":"10.1111\/1469-0691.12380","volume":"20","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio, M. et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20, O245\u2013O254 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR15","doi-asserted-by":"publisher","first-page":"O50","DOI":"10.1111\/1469-0691.12312","volume":"20","author":"MN Gamaletsou","year":"2014","unstructured":"Gamaletsou, M. N. et al. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clin Microbiol Infect 20, O50\u2013O57 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR16","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/jac\/dkt283","volume":"68","author":"GM Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez, G. M. et al. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study. J Antimicrob Chemother 68, 2847\u20132851 (2013).","journal-title":"J Antimicrob Chemother"},{"key":"33662_CR17","first-page":"1942","volume":"21","author":"DS Jung","year":"2015","unstructured":"Jung, D. S., Farmakiotis, D., Jiang, Y., Tarrand, J. J. & Kontoyiannis, D. P. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerg Infect Dis 21, 1942\u20131950 (2015).","journal-title":"Emerg Infect Dis"},{"key":"33662_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1469-0691.2009.02821.x","volume":"15","author":"SC Chen","year":"2009","unstructured":"Chen, S. C. et al. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 15, 662\u2013669 (2009).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR19","doi-asserted-by":"publisher","first-page":"1018.e1","DOI":"10.1016\/j.cmi.2015.06.024","volume":"21","author":"MH Tsai","year":"2015","unstructured":"Tsai, M. H. et al. Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011. Clin Microbiol Infect 21, 1018.e1\u20131018.e8 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/JCM.01840-06","volume":"45","author":"BD Alexander","year":"2007","unstructured":"Alexander, B. D. et al. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 45, 698\u2013706 (2007).","journal-title":"J Clin Microbiol"},{"key":"33662_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/1469-0691.12440","volume":"20","author":"C Orasch","year":"2014","unstructured":"Orasch, C. et al. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect 20, 698\u2013705 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR22","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: 4th informational supplement. Document M27-S4. Wayne, PA: CLSI (2012)."},{"key":"33662_CR23","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M. A. & Diekema, D. J. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 50, 2846\u20132856 (2012).","journal-title":"J Clin Microbiol"},{"key":"33662_CR24","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/INF.0000000000000039","volume":"33","author":"ME Santolaya","year":"2014","unstructured":"Santolaya, M. E. et al. Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome. Pediatr Infect Dis J 33, e40\u2013e44 (2014).","journal-title":"Pediatr Infect Dis J"},{"key":"33662_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/cid\/cis200","volume":"54","author":"MH Nguyen","year":"2012","unstructured":"Nguyen, M. H. et al. Performance of Candida real-time polymerase chain reaction, \u03b2-D-Glucan Assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54, 1240\u20131248 (2012).","journal-title":"Clin Infect Dis"},{"key":"33662_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel, L. A. et al. Clinical practice gudelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49, 1\u201345 (2009).","journal-title":"Clin Infect Dis"},{"key":"33662_CR27","doi-asserted-by":"publisher","first-page":"277.e11","DOI":"10.1016\/j.cmi.2015.10.023","volume":"22","author":"P Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz, P. et al. Risk factors for late recurrent candidaemia. A retrospective matched case-control study. Clin Microbiol Infect 22, 277.e11\u2013277.e20 (2016).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR28","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1542\/peds.2013-1248","volume":"133","author":"MH Tsai","year":"2014","unstructured":"Tsai, M. H. et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics 133, e322\u2013e329 (2014).","journal-title":"Pediatrics"},{"key":"33662_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01123-6","volume":"7","author":"MH Tsai","year":"2017","unstructured":"Tsai, M. H. et al. Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia. Sci Rep 7, 1083 (2017).","journal-title":"Sci Rep"},{"key":"33662_CR30","doi-asserted-by":"publisher","first-page":"O952","DOI":"10.1111\/1469-0691.12688","volume":"20","author":"N Lerolle","year":"2014","unstructured":"Lerolle, N. et al. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect 20, O952\u2013O959 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cmi.2015.07.005","volume":"21","author":"T Brosh-Nissimov","year":"2015","unstructured":"Brosh-Nissimov, T. & Ben-Ami, R. Differential association of fluconazole does and does\/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection. Clin Microbiol Infect 21, 1011\u20131017 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"33662_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/INF.0b013e31824da7fe","volume":"31","author":"J Dotis","year":"2012","unstructured":"Dotis, J., Prasad, P. A., Zaoutis, T. & Roilides, E. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J 31, 557\u2013560 (2012).","journal-title":"Pediatr Infect Dis J"},{"key":"33662_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal, B. H. et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 47, 674\u2013683 (2008).","journal-title":"Clin Infect Dis"},{"key":"33662_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","volume":"31","author":"WJ Steinbach","year":"2012","unstructured":"Steinbach, W. J. et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 31, 1252\u20131257 (2012).","journal-title":"Pediatr Infect Dis J"},{"key":"33662_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1086\/503410","volume":"22","author":"A Rodriguez-Nunez","year":"2001","unstructured":"Rodriguez-Nunez, A. Incidence and mortality of proven invasive Candida infections in pediatric intensive care patients. Infect Control Hosp Epidemiol 22, 477\u2013478 (2001).","journal-title":"Infect Control Hosp Epidemiol"},{"key":"33662_CR36","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1007\/s00134-013-3057-y","volume":"39","author":"L Vogiatzi","year":"2013","unstructured":"Vogiatzi, L. et al. Invasive candidiasis in pediatric intensive care in Greece: a nationwide study. Intensive Care Med 39, 2188\u20132195 (2013).","journal-title":"Intensive Care Med"},{"key":"33662_CR37","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/INF.0000000000000274","volume":"2014","author":"I Jordan","year":"2014","unstructured":"Jordan, I. et al. Per-species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems. Pediatr Infect Dis J 2014, e187\u2013e193 (2014).","journal-title":"Pediatr Infect Dis J"},{"key":"33662_CR38","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1086\/529435","volume":"46","author":"JK Chow","year":"2008","unstructured":"Chow, J. K. et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46, 1206\u20131213 (2008).","journal-title":"Clin Infect Dis"},{"key":"33662_CR39","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1097\/CCM.0b013e3181760f42","volume":"36","author":"EG Playford","year":"2008","unstructured":"Playford, E. G. et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 36, 2034\u20132039 (2008).","journal-title":"Crit Care Med"},{"key":"33662_CR40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/INF.0b013e318213da0f","volume":"30","author":"A Dutta","year":"2011","unstructured":"Dutta, A. & Palazzi, D. L. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 30, 664\u2013668 (2011).","journal-title":"Pediatr Infect Dis J"},{"key":"33662_CR41","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/JCM.05474-11","volume":"49","author":"J Pem\u00e1n","year":"2011","unstructured":"Pem\u00e1n, J. et al. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey. J Clin Microbiol 49, 4158\u20134163 (2011).","journal-title":"J Clin Microbiol"},{"key":"33662_CR42","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","volume":"42","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio, M. et al. Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 42, 1423\u20131432 (2014).","journal-title":"Crit Care Med"},{"key":"33662_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/ciu158","volume":"58","author":"M Fern\u00e1ndez-Ruiz","year":"2014","unstructured":"Fern\u00e1ndez-Ruiz, M. et al. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. Clin Infect Dis 58, 1413\u20131421 (2014).","journal-title":"Clin Infect Dis"},{"key":"33662_CR44","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti, M. et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41, 1601\u20131610 (2015).","journal-title":"Intensive Care Med"},{"key":"33662_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2012.05.024","volume":"40","author":"CC Lai","year":"2012","unstructured":"Lai, C. C. et al. Association between incidence of candidemia and consumption of antifungal agents at a medical center in Taiwan. Int J Antimicrob Agents 40, 349\u2013353 (2012).","journal-title":"Int J Antimicrob Agents"},{"key":"33662_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jac\/dkp251","volume":"64","author":"M Bassetti","year":"2009","unstructured":"Bassetti, M. et al. Incidence of candidemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 64, 625\u2013629 (2009).","journal-title":"J Antimicrob Chemother"},{"key":"33662_CR47","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 updated by the Infectious Disease Society of America. Clin Infect Dis 62, e1\u201350 (2016).","journal-title":"Clin Infect Dis"},{"key":"33662_CR48","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1128\/JCM.00131-14","volume":"52","author":"SF Dufresne","year":"2014","unstructured":"Dufresne, S. F. et al. Epidemiology of Candida kefyr in patients with hematologic malignancies. J Clin Microbiol 52, 1830\u20131837 (2014).","journal-title":"J Clin Microbiol"},{"issue":"2","key":"33662_CR49","doi-asserted-by":"publisher","first-page":"e11895","DOI":"10.5812\/pedinfect.11895","volume":"6","author":"A Charsizadeh","year":"2018","unstructured":"Charsizadeh, A. et al. Candidemia in children caused by uncommon species of Candida. Arch Pediatr Infect Dis 6(2), e11895 (2018).","journal-title":"Arch Pediatr Infect Dis"},{"key":"33662_CR50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","volume":"6","author":"N Singhal","year":"2015","unstructured":"Singhal, N., Kumar, M., Kanaujai, P. K. & Virdi, J. S. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol 6, 791 (2015).","journal-title":"Front Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33662-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:41:15Z","timestamp":1671619275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33662-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33662"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33662-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15239"}}